SCHEMBL8010989

SCHEMBL8010989

N=C(N)N1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.68
CYP2C19 P33261 2/20 0.68
MEN1 O00255 1/20 0.64
KMT2A Q03164 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
NPC1 O15118 4/20 0.62
RAB9A P51151 4/20 0.62
MAPK1 P28482 1/20 0.55
L3MBTL1 Q9Y468 2/20 0.54
CYP2C9 P11712 2/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 1/20 0.51
ALDH1A1 P00352 1/20 0.51
CYP1A2 P05177 1/20 0.51
POLB P06746 1/20 0.51
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA7 P43166 2/20 0.50
CA9 Q16790 2/20 0.50
GRIN2B Q13224 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL379160 0.90 MEN1 (0.76) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL3970912 0.90 MEN1 (0.76) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL7393652 0.90 MEN1 (0.76) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL4814264 0.90 MEN1 (0.76) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL15011579 0.89 MEN1 (0.73) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
Bicarbonate SCHEMBL4357688 0.89 MEN1 (0.73) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL7658562 0.87 L3MBTL1 (0.68) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL1259833 0.86 SMN1; SMN2 (0.66) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL1675680 0.86 MEN1 (0.66) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1
SCHEMBL27630267 0.86 MEN1 (0.66) SMN1; SMN2CYP2C19MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1864976-A1 PROPANE-1,3-DION DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2007-12-12 EP disclosed
US-6083949-A FOR TREATING CANCER IN WHICH RAF KINASE IS IMPLICATED, AS WELL AS COMPOUNDS WHICH INHIBIT, SUPPRESS OR ANTAGONIZE THE PRODUCTION OR ACTIVITY OF CYTOKINES SUCH AS INTERLEUKINS AND TUMOR NECROSIS FACTOR MERCK & CO., INC. (US) 2000-07-04 US disclosed